As we step into 2026, the healthcare private equity landscape is defined by both powerful momentum and meaningful constraints. Record levels of dry powder and a growing pipeline of high‑quality assets suggest increased deal activity, while stabilizing macroeconomic conditions and the potential for interest‑rate relief offer real tailwinds.
Please see full publication below for more information.
